Novartis Investigative Site

Lyon, France 69003

0 studies enrolling now · 2 studies all time

What they study most

Lymphangioleiomyomatosis (LAM), Post-menopausal Osteoporosis, Tuberous Sclerosis Complex (TSC)

Studies at this site

• Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) — Completed
• 3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs — Completed